(3S,8R,9S,10R,13S,14S)-16-formyl-17-(1H-imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

ID: ALA3342906

Chembl Id: CHEMBL3342906

PubChem CID: 10740227

Max Phase: Preclinical

Molecular Formula: C25H32N2O3

Molecular Weight: 408.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(n4ccnc4)=C(C=O)C[C@@H]32)C1

Standard InChI:  InChI=1S/C25H32N2O3/c1-16(29)30-19-6-8-24(2)18(13-19)4-5-20-21(24)7-9-25(3)22(20)12-17(14-28)23(25)27-11-10-26-15-27/h4,10-11,14-15,19-22H,5-9,12-13H2,1-3H3/t19-,20+,21-,22-,24-,25-/m0/s1

Standard InChI Key:  ZDYHFZKELXEXOP-JMTDQOONSA-N

Associated Targets(Human)

SRD5A2 Tclin Steroid 5-alpha-reductase 2 (937 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Srd5a1 Steroid 5-alpha-reductase 1 (193 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ar Androgen Receptor (5522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.54Molecular Weight (Monoisotopic): 408.2413AlogP: 4.80#Rotatable Bonds: 3
Polar Surface Area: 61.19Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.10CX LogP: 2.78CX LogD: 2.76
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.41Np Likeness Score: 1.19

References

1. Bratoeff E, Garrido M, Ramírez-Apan T, Heuze Y, Sánchez A, Soriano J, Cabeza M..  (2014)  Effect of dehydroepiandrosterone derivatives on the activity of 5α-reductase isoenzymes and on cancer cell line PC-3.,  22  (21): [PMID:25261928] [10.1016/j.bmc.2014.08.019]

Source